At the same time, the duration of infectious disease was lower among patients on thiopurines, and biological treatment seemed to be related to a decreased risk of severe COVID-19 (borderline significance).
← all excerpts
Inflammatory bowel diseases and the clinical course of coronavirus disease 2019 - a Polish single-centre experience from the pre-vaccine era.
1
—
—